SREBF1 and colorectal carcinoma: In colorectal cancer (CRC) patients, the upregulation of caspase-7 caused by downregulation of sterol regulatory element binding proteins (SREBP1) may improve chemosensitivity to gemcitabine in CRC cells, which may serve as a novel prognostic biomarker for CRC [37].